Skinvisible, Inc. SEC filings SKVI

Skinvisible, Inc. has 391 filings in SEC EDGAR's recent list, going back to Apr 30, 1999. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jan 23, 2025 (regulation fd disclosure). The company's fiscal year ends on December 31.

Form Description Filed Period
DEF 14A Proxy statement Oct 19, 2018 Oct 19, 2018
PREM14A Filing May 2, 2018 May 2, 2018
DEF 14A Proxy statement Aug 15, 2008 Sep 5, 2008
PRE 14A Preliminary proxy statement Aug 5, 2008 Sep 5, 2008
DEF 14A Proxy statement Aug 4, 2006 Aug 31, 2006
PRE 14A Preliminary proxy statement Jul 21, 2006 Aug 31, 2006
DEF 14A Proxy statement Dec 22, 2004 Dec 20, 2004
DEF 14A Proxy statement Nov 17, 2003 Nov 17, 2003
DEF 14A Proxy statement Jul 3, 2001 Jul 20, 2001
PRE 14A Preliminary proxy statement Jun 19, 2001 Jul 20, 2001
DEF 14A Proxy statement Dec 2, 1999 Dec 22, 1999

Showing 11 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
SKVI (OTC)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
Las Vegas, NV
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1085277
Former names
SKINVISIBLE INC (until Aug 14, 2019)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.